Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has announced the issuance of 125 million unquoted options expiring in May 2027 with an exercise price of $0.150, as detailed in their latest Appendix 3G filing. These securities are part of a transaction previously disclosed to the market and will not be quoted on the ASX.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
